Global Cancer Biotherapy Market Growth (Status and Outlook) 2025-2031

September 2025 | 72 pages | ID: G6507AFDB79EN
LP Information

Abstracts

According to this study, the global Cancer Biotherapy market size will reach US$ million by 2031.

Cancer biotherapy is a form of treatment that uses the natural immune system to protect the body against cancer.

United States market for Cancer Biotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cancer Biotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cancer Biotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cancer Biotherapy players cover Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Eli Lilly, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Cancer Biotherapy Industry Forecast” looks at past sales and reviews total world Cancer Biotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Cancer Biotherapy sales for 2025 through 2031. With Cancer Biotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Biotherapy industry.

This Insight Report provides a comprehensive analysis of the global Cancer Biotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cancer Biotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cancer Biotherapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Biotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Biotherapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Biotherapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Monoclonal Antibodies
• Vaccines
• Erythropoietin
• Colony Stimulating Factors
• Interleukins and Interferons

Segmentation by Application:

• Hospitals
• Diagnostic Laboratories
• Research and Academic Laboratories
• Pharmaceutical and Biotechnology Companies
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Amgen
• Bristol-Myers Squibb
• Celgene
• GlaxoSmithKline
• Eli Lilly

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cancer Biotherapy Market Size (2020-2031)
  2.1.2 Cancer Biotherapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Cancer Biotherapy by Country/Region (2020, 2024 & 2031)
2.2 Cancer Biotherapy Segment by Type
  2.2.1 Monoclonal Antibodies
  2.2.2 Vaccines
  2.2.3 Erythropoietin
  2.2.4 Colony Stimulating Factors
  2.2.5 Interleukins and Interferons
2.3 Cancer Biotherapy Market Size by Type
  2.3.1 Cancer Biotherapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Cancer Biotherapy Market Size Market Share by Type (2020-2025)
2.4 Cancer Biotherapy Segment by Application
  2.4.1 Hospitals
  2.4.2 Diagnostic Laboratories
  2.4.3 Research and Academic Laboratories
  2.4.4 Pharmaceutical and Biotechnology Companies
  2.4.5 Others
2.5 Cancer Biotherapy Market Size by Application
  2.5.1 Cancer Biotherapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Cancer Biotherapy Market Size Market Share by Application (2020-2025)

3 CANCER BIOTHERAPY MARKET SIZE BY PLAYER

3.1 Cancer Biotherapy Market Size Market Share by Player
  3.1.1 Global Cancer Biotherapy Revenue by Player (2020-2025)
  3.1.2 Global Cancer Biotherapy Revenue Market Share by Player (2020-2025)
3.2 Global Cancer Biotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CANCER BIOTHERAPY BY REGION

4.1 Cancer Biotherapy Market Size by Region (2020-2025)
4.2 Global Cancer Biotherapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cancer Biotherapy Market Size Growth (2020-2025)
4.4 APAC Cancer Biotherapy Market Size Growth (2020-2025)
4.5 Europe Cancer Biotherapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Cancer Biotherapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Cancer Biotherapy Market Size by Country (2020-2025)
5.2 Americas Cancer Biotherapy Market Size by Type (2020-2025)
5.3 Americas Cancer Biotherapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cancer Biotherapy Market Size by Region (2020-2025)
6.2 APAC Cancer Biotherapy Market Size by Type (2020-2025)
6.3 APAC Cancer Biotherapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cancer Biotherapy Market Size by Country (2020-2025)
7.2 Europe Cancer Biotherapy Market Size by Type (2020-2025)
7.3 Europe Cancer Biotherapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cancer Biotherapy by Region (2020-2025)
8.2 Middle East & Africa Cancer Biotherapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Cancer Biotherapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CANCER BIOTHERAPY MARKET FORECAST

10.1 Global Cancer Biotherapy Forecast by Region (2026-2031)
  10.1.1 Global Cancer Biotherapy Forecast by Region (2026-2031)
  10.1.2 Americas Cancer Biotherapy Forecast
  10.1.3 APAC Cancer Biotherapy Forecast
  10.1.4 Europe Cancer Biotherapy Forecast
  10.1.5 Middle East & Africa Cancer Biotherapy Forecast
10.2 Americas Cancer Biotherapy Forecast by Country (2026-2031)
  10.2.1 United States Market Cancer Biotherapy Forecast
  10.2.2 Canada Market Cancer Biotherapy Forecast
  10.2.3 Mexico Market Cancer Biotherapy Forecast
  10.2.4 Brazil Market Cancer Biotherapy Forecast
10.3 APAC Cancer Biotherapy Forecast by Region (2026-2031)
  10.3.1 China Cancer Biotherapy Market Forecast
  10.3.2 Japan Market Cancer Biotherapy Forecast
  10.3.3 Korea Market Cancer Biotherapy Forecast
  10.3.4 Southeast Asia Market Cancer Biotherapy Forecast
  10.3.5 India Market Cancer Biotherapy Forecast
  10.3.6 Australia Market Cancer Biotherapy Forecast
10.4 Europe Cancer Biotherapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Cancer Biotherapy Forecast
  10.4.2 France Market Cancer Biotherapy Forecast
  10.4.3 UK Market Cancer Biotherapy Forecast
  10.4.4 Italy Market Cancer Biotherapy Forecast
  10.4.5 Russia Market Cancer Biotherapy Forecast
10.5 Middle East & Africa Cancer Biotherapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Cancer Biotherapy Forecast
  10.5.2 South Africa Market Cancer Biotherapy Forecast
  10.5.3 Israel Market Cancer Biotherapy Forecast
  10.5.4 Turkey Market Cancer Biotherapy Forecast
10.6 Global Cancer Biotherapy Forecast by Type (2026-2031)
10.7 Global Cancer Biotherapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Cancer Biotherapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Amgen
  11.1.1 Amgen Company Information
  11.1.2 Amgen Cancer Biotherapy Product Offered
  11.1.3 Amgen Cancer Biotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Amgen Main Business Overview
  11.1.5 Amgen Latest Developments
11.2 Bristol-Myers Squibb
  11.2.1 Bristol-Myers Squibb Company Information
  11.2.2 Bristol-Myers Squibb Cancer Biotherapy Product Offered
  11.2.3 Bristol-Myers Squibb Cancer Biotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bristol-Myers Squibb Main Business Overview
  11.2.5 Bristol-Myers Squibb Latest Developments
11.3 Celgene
  11.3.1 Celgene Company Information
  11.3.2 Celgene Cancer Biotherapy Product Offered
  11.3.3 Celgene Cancer Biotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Celgene Main Business Overview
  11.3.5 Celgene Latest Developments
11.4 GlaxoSmithKline
  11.4.1 GlaxoSmithKline Company Information
  11.4.2 GlaxoSmithKline Cancer Biotherapy Product Offered
  11.4.3 GlaxoSmithKline Cancer Biotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 GlaxoSmithKline Main Business Overview
  11.4.5 GlaxoSmithKline Latest Developments
11.5 Eli Lilly
  11.5.1 Eli Lilly Company Information
  11.5.2 Eli Lilly Cancer Biotherapy Product Offered
  11.5.3 Eli Lilly Cancer Biotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Eli Lilly Main Business Overview
  11.5.5 Eli Lilly Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cancer Biotherapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Cancer Biotherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Vaccines
Table 5. Major Players of Erythropoietin
Table 6. Major Players of Colony Stimulating Factors
Table 7. Major Players of Interleukins and Interferons
Table 8. Cancer Biotherapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Cancer Biotherapy Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Cancer Biotherapy Market Size Market Share by Type (2020-2025)
Table 11. Cancer Biotherapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Cancer Biotherapy Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Cancer Biotherapy Market Size Market Share by Application (2020-2025)
Table 14. Global Cancer Biotherapy Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Cancer Biotherapy Revenue Market Share by Player (2020-2025)
Table 16. Cancer Biotherapy Key Players Head office and Products Offered
Table 17. Cancer Biotherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Cancer Biotherapy Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Cancer Biotherapy Market Size Market Share by Region (2020-2025)
Table 22. Global Cancer Biotherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Cancer Biotherapy Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Cancer Biotherapy Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Cancer Biotherapy Market Size Market Share by Country (2020-2025)
Table 26. Americas Cancer Biotherapy Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Cancer Biotherapy Market Size Market Share by Type (2020-2025)
Table 28. Americas Cancer Biotherapy Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Cancer Biotherapy Market Size Market Share by Application (2020-2025)
Table 30. APAC Cancer Biotherapy Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Cancer Biotherapy Market Size Market Share by Region (2020-2025)
Table 32. APAC Cancer Biotherapy Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Cancer Biotherapy Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Cancer Biotherapy Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Cancer Biotherapy Market Size Market Share by Country (2020-2025)
Table 36. Europe Cancer Biotherapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Cancer Biotherapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Cancer Biotherapy Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Cancer Biotherapy Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Cancer Biotherapy Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Cancer Biotherapy
Table 42. Key Market Challenges & Risks of Cancer Biotherapy
Table 43. Key Industry Trends of Cancer Biotherapy
Table 44. Global Cancer Biotherapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Cancer Biotherapy Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Cancer Biotherapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Cancer Biotherapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Amgen Details, Company Type, Cancer Biotherapy Area Served and Its Competitors
Table 49. Amgen Cancer Biotherapy Product Offered
Table 50. Amgen Cancer Biotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Amgen Main Business
Table 52. Amgen Latest Developments
Table 53. Bristol-Myers Squibb Details, Company Type, Cancer Biotherapy Area Served and Its Competitors
Table 54. Bristol-Myers Squibb Cancer Biotherapy Product Offered
Table 55. Bristol-Myers Squibb Cancer Biotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Bristol-Myers Squibb Main Business
Table 57. Bristol-Myers Squibb Latest Developments
Table 58. Celgene Details, Company Type, Cancer Biotherapy Area Served and Its Competitors
Table 59. Celgene Cancer Biotherapy Product Offered
Table 60. Celgene Cancer Biotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Celgene Main Business
Table 62. Celgene Latest Developments
Table 63. GlaxoSmithKline Details, Company Type, Cancer Biotherapy Area Served and Its Competitors
Table 64. GlaxoSmithKline Cancer Biotherapy Product Offered
Table 65. GlaxoSmithKline Cancer Biotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. GlaxoSmithKline Main Business
Table 67. GlaxoSmithKline Latest Developments
Table 68. Eli Lilly Details, Company Type, Cancer Biotherapy Area Served and Its Competitors
Table 69. Eli Lilly Cancer Biotherapy Product Offered
Table 70. Eli Lilly Cancer Biotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Eli Lilly Main Business
Table 72. Eli Lilly Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Biotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Biotherapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Cancer Biotherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Cancer Biotherapy Sales Market Share by Country/Region (2024)
Figure 8. Cancer Biotherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Cancer Biotherapy Market Size Market Share by Type in 2024
Figure 10. Cancer Biotherapy in Hospitals
Figure 11. Global Cancer Biotherapy Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Cancer Biotherapy in Diagnostic Laboratories
Figure 13. Global Cancer Biotherapy Market: Diagnostic Laboratories (2020-2025) & ($ millions)
Figure 14. Cancer Biotherapy in Research and Academic Laboratories
Figure 15. Global Cancer Biotherapy Market: Research and Academic Laboratories (2020-2025) & ($ millions)
Figure 16. Cancer Biotherapy in Pharmaceutical and Biotechnology Companies
Figure 17. Global Cancer Biotherapy Market: Pharmaceutical and Biotechnology Companies (2020-2025) & ($ millions)
Figure 18. Cancer Biotherapy in Others
Figure 19. Global Cancer Biotherapy Market: Others (2020-2025) & ($ millions)
Figure 20. Global Cancer Biotherapy Market Size Market Share by Application in 2024
Figure 21. Global Cancer Biotherapy Revenue Market Share by Player in 2024
Figure 22. Global Cancer Biotherapy Market Size Market Share by Region (2020-2025)
Figure 23. Americas Cancer Biotherapy Market Size 2020-2025 ($ millions)
Figure 24. APAC Cancer Biotherapy Market Size 2020-2025 ($ millions)
Figure 25. Europe Cancer Biotherapy Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Cancer Biotherapy Market Size 2020-2025 ($ millions)
Figure 27. Americas Cancer Biotherapy Value Market Share by Country in 2024
Figure 28. United States Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Cancer Biotherapy Market Size Market Share by Region in 2024
Figure 33. APAC Cancer Biotherapy Market Size Market Share by Type (2020-2025)
Figure 34. APAC Cancer Biotherapy Market Size Market Share by Application (2020-2025)
Figure 35. China Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 39. India Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Cancer Biotherapy Market Size Market Share by Country in 2024
Figure 42. Europe Cancer Biotherapy Market Size Market Share by Type (2020-2025)
Figure 43. Europe Cancer Biotherapy Market Size Market Share by Application (2020-2025)
Figure 44. Germany Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 45. France Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Cancer Biotherapy Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Cancer Biotherapy Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Cancer Biotherapy Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Cancer Biotherapy Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 58. APAC Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 59. Europe Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 61. United States Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 62. Canada Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 63. Mexico Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 64. Brazil Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 65. China Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 66. Japan Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 67. Korea Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 69. India Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 70. Australia Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 71. Germany Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 72. France Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 73. UK Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 74. Italy Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 75. Russia Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 76. Egypt Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 77. South Africa Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 78. Israel Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 79. Turkey Cancer Biotherapy Market Size 2026-2031 ($ millions)
Figure 80. Global Cancer Biotherapy Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Cancer Biotherapy Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Cancer Biotherapy Market Size 2026-2031 ($ millions)